TME PHARM.CONF.IPO EO 1-
Healthcare · EUR · F
Price
€0.074
Cap
€5.91M
Earnings
—
30d Trend
+2.8%
83% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 32×Macro 0.99 (−1%)=32
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
6-9 month opportunity — emerging trend
BRAIN47'S ASSESSMENT
I rate TME PHARM.CONF.IPO EO 1- at 32/100 — a WEAK reading on the Brain47 Signal. The strongest factor is technical at 50/100. I classify this as a speculative position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
+7.2%
3 MONTHS
+15.6%
12 MONTHS
-7.5%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
6-9 month opportunity — emerging trend. Technical (50) and Momentum (45) are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 83%. I classify this as a speculative position — elevated volatility at 83% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.